Sanofi in sales mode: Talks about Opella stake with US company

The French pharmaceutical company Sanofi has confirmed that it has entered into negotiations with the American private equity firm Clayton Dubilier & Rice to sell a 50 percent majority stake in its self-medication business, Opella. This development follows earlier reports valuing the sale at approximately 15 billion euros. Although Sanofi has not yet provided specific financial details regarding the potential deal, the company promises to release further information in the near future and to keep the public informed. With this strategic move, Sanofi is dismantling another piece of its extensive corporate structure. Given the shifting priorities in the pharmaceutical sector, this sale appears to align with the growth strategy for other business areas.